A Study Evaluating the Safety of ABT-263 in Combination With Etoposide/Cisplatin in Subjects With Cancer
Clinical trial NCT00878449 · COMPLETED
Trial details
- NCT number
- NCT00878449
- Sponsor
- AbbVie (prior sponsor, Abbott)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2009-10-01
- Primary completion
- 2011-07-01
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.